Article Details

CureVac Settles Patent Dispute with Pfizer and BioNTech for $500 Million, GSK to Receive 1 ...

Retrieved on: 2025-08-08 20:10:20

Tags for this article:

Click the tags to see associated articles and topics

CureVac Settles Patent Dispute with Pfizer and BioNTech for $500 Million, GSK to Receive 1 .... View article details on hiswai:

Excerpt

... BioNTech. The settlement comes as BioNTech completes its acquisition of CureVac. GSK will receive $370 million upfront and another $130 million on ...

Article found on: www.ainvest.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo